Tag: global oligonucleotide synthesis market

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Global Market Value Of The Oligonucleotide Synthesis Industry In 2025?

The oligonucleotide synthesis market has experienced substantial growth in recent years. It is projected to expand from $10.33 billion in 2024 to $11.92 billion in 2025, reflecting a compound annual growth rate (CAGR) of 15.3%. This historical expansion can be primarily attributed to advances in biomedical research, progress in therapeutic development, innovations within biotechnology, the prevalence of genomic studies, and the growing application of DNA technologies.

The oligonucleotide synthesis market is projected to experience substantial expansion over the coming years. By 2029, this market is anticipated to reach $22.2 billion, demonstrating a compound annual growth rate (CAGR) of 16.8%. Several factors contribute to this projected growth, including the emergence of new diagnostic tools, RNA interference (RNAi) therapies, applications in regenerative medicine and nanotechnology, and progress in gene editing techniques. Key trends influencing the market during this period encompass targeted drug development, the introduction of innovative delivery systems, advancements in automated synthesis, the adoption of CRISPR-cas technology, and next-generation sequencing (NGS).

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12176&type=smp

Which Major Market Drivers Are Shaping The Future Of The Oligonucleotide Synthesis Market?

The increasing incidence of chronic illnesses is anticipated to drive the expansion of the oligonucleotide synthesis market in the future. These conditions are defined as ailments persisting for a year or more, demanding ongoing medical care and potentially deteriorating over time. Oligonucleotides exert their effects through diverse mechanisms by influencing gene expression implicated in chronic diseases. Specifically, they can target messenger RNA (mRNA), precursor messenger RNA (pre-mRNA), or non-coding RNA to adjust splicing, trigger degradation, or disrupt protein synthesis. As an illustration, the World Health Organization, a Switzerland-based specialized agency of the United Nations, reported in September 2022 that non-communicable diseases (NCDs), or chronic diseases, were responsible for 41 million deaths annually worldwide, accounting for 74% of all fatalities. Of these, cardiovascular diseases led to 17.9 million deaths, cancer to 9.3 million deaths, chronic respiratory diseases to 4.1 million deaths, and diabetes to 2.0 million deaths. Consequently, the growing occurrence of chronic and rare diseases is fueling the expansion of the oligonucleotide synthesis market.

What Are The Different Segment Classifications Within The Oligonucleotide Synthesis Market?

The oligonucleotide synthesismarket covered in this report is segmented –

1) By Type: Custom Oligos; Predesigned Oligos

2) By Product Type: Oligonucleotides; Reagents; Equipment; Services; Purification; Modification

3) By Application: Therapeutic Applications; Research Applications; Diagnostic Applications

Subsegments:

1) By Custom Oligos: Long Oligonucleotides; Short Oligonucleotides; Modified Oligonucleotides

2) By Predesigned Oligos: Gene-Specific Oligos; Probe Oligos; Primers For PCR And RT-PCR

How Are Trends Influencing The Oligonucleotide Synthesis Market?

Product innovation is a significant trend increasing in popularity within the oligonucleotide synthesis market. Leading companies are creating advanced products to sustain their standing in the market. For example, in July 2024, Ansa Biotechnologies, Inc., a US-based company focused on manufacturing complex DNA, launched Ansa Clonal DNA and Ansa DNA Fragments. Ansa Clonal DNA delivers clonal, sequence-perfect DNA up to 600 base pairs in length, thereby eliminating the necessity for assembly and offering exceptional accuracy for intricate synthetic biology projects. This product ensures faultless, pre-prepared DNA sequences, making it a reliable choice for scientific researchers. Ansa DNA Fragments provides sequence-verified linear double-stranded DNA fragments, also up to 600 base pairs, customized for a variety of research applications. Utilizing its innovative enzymatic synthesis process, Ansa reliably generates complex DNA constructs, including repeats and secondary structures, with high precision.

Who Are The Key Multinational Companies Dominating The Oligonucleotide Synthesis Market?

Major companies operating in the oligonucleotide synthesis market include Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, GE HealthCare Technologies Inc., Eurofins Scientific SE, Agilent Technologies Inc., Nitto Denko Avecia Inc., Alnylam Pharmaceuticals Inc., Maravai Life Sciences, LGC Limited, Ionis Pharmaceuticals Inc., GenScript Inc., Ajinomoto Bio-Pharma Services, Sarepta Therapeutics Inc., Integrated DNA Technologies Inc., Twist Bioscience Corporation, Eurogentec SA, Kaneka Eurogentec S.A., Biocomma Limited, Bio-Synthesis Inc., TriLink BioTechnologies Incorporated, Generi Biotech s.r.o., ATDBio Ltd., BioAutomation Corporation, Biolegio B.V., Dharmacon Research Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/oligonucleotide-synthesis-global-market-report

Which Geographies Are Emerging As Strong Markets For The Oligonucleotide Synthesis Industry?

North America was the largest region in the oligonucleotide synthesis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oligonucleotide synthesis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Oligonucleotide Synthesis Market Report:

https://www.thebusinessresearchcompany.com/customise?id=12176&type=smp

Browse Through More Reports Similar to the Global Oligonucleotide Synthesis Market 2025, By The Business Research Company

Face Creams Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/face-creams-global-market-report

Hand Cream And Hand Lotions Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hand-cream-and-hand-lotions-global-market-report

Luxury Bath And Body Products Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/luxury-bath-and-body-products-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Oligonucleotide Synthesis Market Growth in 2025?

In recent times, the market size for oligonucleotide synthesis has observed quick expansion. The market, which was valued at $10.33 billion in 2024, is predicted to surge to $11.94 billion in 2025, experiencing a compound annual growth rate (CAGR) of 15.6%. The upward growth trend in the past years can be credited to the progress in biomedical research, therapeutic development, biotechnological breakthroughs, genomic research, and the rise in DNA technologies.

What Is the Forecast for the Oligonucleotide Synthesis Market Size Through 2029?

In the forthcoming years, a swift expansion is anticipated in the oligonucleotide synthesis market size, with projections putting it at $22.29 billion in 2029, reflecting a compound annual growth rate (CAGR) of 16.9%. The growth trajectory during the forecast period is anticipated to be driven by advancements in diagnostic tools, RNA interference (RNAi) therapies, regenerative medicine, applications of nanotechnology, and progress in gene editing. The projected period also expects to see significant trends such as targeted drug development, innovative delivery systems, automation in synthesis, the use of CRISPR-cas technology, and the rise of next-generation sequencing (NGS).

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12176&type=smp

What are the Key Market Players in Oligonucleotide Synthesis Market and How They’re Evolving?

Major companies operating in the oligonucleotide synthesis market include Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, GE HealthCare Technologies Inc., Eurofins Scientific SE, Agilent Technologies Inc., Nitto Denko Avecia Inc., Alnylam Pharmaceuticals Inc., Maravai Life Sciences, LGC Limited, Ionis Pharmaceuticals Inc., GenScript Inc., Ajinomoto Bio-Pharma Services, Sarepta Therapeutics Inc., Integrated DNA Technologies Inc., Twist Bioscience Corporation, Eurogentec SA, Kaneka Eurogentec S.A., Biocomma Limited, Bio-Synthesis Inc., TriLink BioTechnologies Incorporated, Generi Biotech s.r.o., ATDBio Ltd., BioAutomation Corporation, Biolegio B.V., Dharmacon Research Inc.

What Are the Primary Growth Drivers in the Oligonucleotide Synthesis Market?

The growth of the oligonucleotide synthesis market is projected to be fueled by the increasing incidence of chronic diseases. Chronic diseases are defined as conditions that persist for at least a year, necessitating consistent medical care, and may progressively worsen over time. Oligonucleotides function to regulate gene expression involved in chronic diseases through several mechanisms. These can target mRNA, pre-mRNA, or non-coding RNA to manipulate splicing events, instigate degradation, or interfere with protein translation. For example, the World Health Organization, a specialized agency of the United Nations based in Switzerland, reported in September 2022 that there were 41 million deaths worldwide, accounting for 74% of all deaths due to non-communicable diseases (NCDs) or chronic diseases annually. The report detailed 17.9 million deaths from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. Thus, the elevation in the occurrence of chronic and rare diseases is stimulating the expansion of the oligonucleotide synthesis market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=12176&type=smp

What Are the Leading Segments in the Global Oligonucleotide Synthesis Industry?

The oligonucleotide synthesis market covered in this report is segmented –

1) By Type: Custom Oligos, Predesigned Oligos

2) By Product Type: Oligonucleotides, Reagents, Equipment, Services, Purification, Modification

3) By Application: Therapeutic Applications, Research Applications, Diagnostic Applications

Subsegments:

1) By Custom Oligos: Long Oligonucleotides, Short Oligonucleotides, Modified Oligonucleotides

2) By Predesigned Oligos: Gene-Specific Oligos, Probe Oligos, Primers For PCR And RT-PCR

What Are the Key Market Trends in the Oligonucleotide Synthesis Industry?

Product innovation has emerged as a pivotal trend in the oligonucleotide synthesis market, with major players focussing on the development of novel products to consolidate their market presence. For example, Ansa Biotechnologies, Inc., a company based in the US specializing in the manufacture of complex DNA, rolled out Ansa Clonal DNA and Ansa DNA Fragments in July 2024. Ansa Clonal DNA facilitates clonal, flawless sequences of DNA up to 600 base pairs long, negating the need for assembly, and hence delivers unmatched precision for intricate synthetic biology projects. This product guarantees error-free and ready-to-use DNA sequences, positioning it as a trustworthy choice for scientific researchers. Ansa DNA Fragments provides sequence-verified linear double-stranded DNA fragments, which can also be up to 600 base pairs long, customized for a wide array of research uses. Ansa’s innovative enzymatic synthesis method consistently generates complex DNA structures, inclusive of repeats and secondary structures, with high adaptability.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/oligonucleotide-synthesis-global-market-report

What Is the Regional Outlook for the Oligonucleotide Synthesis Market?

North America was the largest region in the oligonucleotide synthesis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oligonucleotide synthesis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12176

This Report Delivers Insight On:

1. How big is the oligonucleotide synthesis market, and how is it changing globally?

2. Who are the major companies in the oligonucleotide synthesis market, and how are they performing?

3. What are the key opportunities and risks in the oligonucleotide synthesis market right now?

4. Which products or customer segments are growing the most in the oligonucleotide synthesis market?

5. What factors are helping or slowing down the growth of the oligonucleotide synthesis market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the oligonucleotide synthesis industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Are the Key Projections for the CAGR of the Oligonucleotide Synthesis Market Size From 2025 to 2034?

In recent times, the market size for oligonucleotide synthesis has observed quick expansion. The market, which was valued at $10.33 billion in 2024, is predicted to surge to $11.94 billion in 2025, experiencing a compound annual growth rate (CAGR) of 15.6%. The upward growth trend in the past years can be credited to the progress in biomedical research, therapeutic development, biotechnological breakthroughs, genomic research, and the rise in DNA technologies.

In the forthcoming years, a swift expansion is anticipated in the oligonucleotide synthesis market size, with projections putting it at $22.29 billion in 2029, reflecting a compound annual growth rate (CAGR) of 16.9%. The growth trajectory during the forecast period is anticipated to be driven by advancements in diagnostic tools, RNA interference (RNAi) therapies, regenerative medicine, applications of nanotechnology, and progress in gene editing. The projected period also expects to see significant trends such as targeted drug development, innovative delivery systems, automation in synthesis, the use of CRISPR-cas technology, and the rise of next-generation sequencing (NGS).

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12176&type=smp

How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theOligonucleotide Synthesis Market?

The growth of the oligonucleotide synthesis market is projected to be fueled by the increasing incidence of chronic diseases. Chronic diseases are defined as conditions that persist for at least a year, necessitating consistent medical care, and may progressively worsen over time. Oligonucleotides function to regulate gene expression involved in chronic diseases through several mechanisms. These can target mRNA, pre-mRNA, or non-coding RNA to manipulate splicing events, instigate degradation, or interfere with protein translation. For example, the World Health Organization, a specialized agency of the United Nations based in Switzerland, reported in September 2022 that there were 41 million deaths worldwide, accounting for 74% of all deaths due to non-communicable diseases (NCDs) or chronic diseases annually. The report detailed 17.9 million deaths from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. Thus, the elevation in the occurrence of chronic and rare diseases is stimulating the expansion of the oligonucleotide synthesis market.

Which Segments in the Oligonucleotide Synthesis Offer the Most Growth?

The oligonucleotide synthesis market covered in this report is segmented –

1) By Type: Custom Oligos, Predesigned Oligos

2) By Product Type: Oligonucleotides, Reagents, Equipment, Services, Purification, Modification

3) By Application: Therapeutic Applications, Research Applications, Diagnostic Applications

Subsegments:

1) By Custom Oligos: Long Oligonucleotides, Short Oligonucleotides, Modified Oligonucleotides

2) By Predesigned Oligos: Gene-Specific Oligos, Probe Oligos, Primers For PCR And RT-PCR

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=12176&type=smp

What Are the Fastest-Growing Geographies in the #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theOligonucleotide Synthesis Market?# Market?

North America was the largest region in the oligonucleotide synthesis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oligonucleotide synthesis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Current Market Growth and Trends in the Oligonucleotide Synthesis Industry?

Product innovation has emerged as a pivotal trend in the oligonucleotide synthesis market, with major players focussing on the development of novel products to consolidate their market presence. For example, Ansa Biotechnologies, Inc., a company based in the US specializing in the manufacture of complex DNA, rolled out Ansa Clonal DNA and Ansa DNA Fragments in July 2024. Ansa Clonal DNA facilitates clonal, flawless sequences of DNA up to 600 base pairs long, negating the need for assembly, and hence delivers unmatched precision for intricate synthetic biology projects. This product guarantees error-free and ready-to-use DNA sequences, positioning it as a trustworthy choice for scientific researchers. Ansa DNA Fragments provides sequence-verified linear double-stranded DNA fragments, which can also be up to 600 base pairs long, customized for a wide array of research uses. Ansa’s innovative enzymatic synthesis method consistently generates complex DNA structures, inclusive of repeats and secondary structures, with high adaptability.

View the full report here:

https://www.thebusinessresearchcompany.com/report/oligonucleotide-synthesis-global-market-report

What Are the Key Elements That Define the Oligonucleotide Synthesis Market?

Oligonucleotide synthesis is the chemical linking of nucleotides, precisely forming the desired sequenced product. This process is helpful in modern laboratory practice as it offers quick and affordable access to oligonucleotides manufactured to order with the necessary sequence.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12176

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the oligonucleotide synthesis industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Are the Key Projections for the CAGR of the Oligonucleotide Synthesis Market Size From 2025 to 2034?

In recent times, the market size for oligonucleotide synthesis has observed quick expansion. The market, which was valued at $10.33 billion in 2024, is predicted to surge to $11.94 billion in 2025, experiencing a compound annual growth rate (CAGR) of 15.6%. The upward growth trend in the past years can be credited to the progress in biomedical research, therapeutic development, biotechnological breakthroughs, genomic research, and the rise in DNA technologies.

In the forthcoming years, a swift expansion is anticipated in the oligonucleotide synthesis market size, with projections putting it at $22.29 billion in 2029, reflecting a compound annual growth rate (CAGR) of 16.9%. The growth trajectory during the forecast period is anticipated to be driven by advancements in diagnostic tools, RNA interference (RNAi) therapies, regenerative medicine, applications of nanotechnology, and progress in gene editing. The projected period also expects to see significant trends such as targeted drug development, innovative delivery systems, automation in synthesis, the use of CRISPR-cas technology, and the rise of next-generation sequencing (NGS).

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12176&type=smp

How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theOligonucleotide Synthesis Market?

The growth of the oligonucleotide synthesis market is projected to be fueled by the increasing incidence of chronic diseases. Chronic diseases are defined as conditions that persist for at least a year, necessitating consistent medical care, and may progressively worsen over time. Oligonucleotides function to regulate gene expression involved in chronic diseases through several mechanisms. These can target mRNA, pre-mRNA, or non-coding RNA to manipulate splicing events, instigate degradation, or interfere with protein translation. For example, the World Health Organization, a specialized agency of the United Nations based in Switzerland, reported in September 2022 that there were 41 million deaths worldwide, accounting for 74% of all deaths due to non-communicable diseases (NCDs) or chronic diseases annually. The report detailed 17.9 million deaths from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. Thus, the elevation in the occurrence of chronic and rare diseases is stimulating the expansion of the oligonucleotide synthesis market.

Which Segments in the Oligonucleotide Synthesis Offer the Most Growth?

The oligonucleotide synthesis market covered in this report is segmented –

1) By Type: Custom Oligos, Predesigned Oligos

2) By Product Type: Oligonucleotides, Reagents, Equipment, Services, Purification, Modification

3) By Application: Therapeutic Applications, Research Applications, Diagnostic Applications

Subsegments:

1) By Custom Oligos: Long Oligonucleotides, Short Oligonucleotides, Modified Oligonucleotides

2) By Predesigned Oligos: Gene-Specific Oligos, Probe Oligos, Primers For PCR And RT-PCR

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=12176&type=smp

What Are the Fastest-Growing Geographies in the #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theOligonucleotide Synthesis Market?# Market?

North America was the largest region in the oligonucleotide synthesis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oligonucleotide synthesis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Current Market Growth and Trends in the Oligonucleotide Synthesis Industry?

Product innovation has emerged as a pivotal trend in the oligonucleotide synthesis market, with major players focussing on the development of novel products to consolidate their market presence. For example, Ansa Biotechnologies, Inc., a company based in the US specializing in the manufacture of complex DNA, rolled out Ansa Clonal DNA and Ansa DNA Fragments in July 2024. Ansa Clonal DNA facilitates clonal, flawless sequences of DNA up to 600 base pairs long, negating the need for assembly, and hence delivers unmatched precision for intricate synthetic biology projects. This product guarantees error-free and ready-to-use DNA sequences, positioning it as a trustworthy choice for scientific researchers. Ansa DNA Fragments provides sequence-verified linear double-stranded DNA fragments, which can also be up to 600 base pairs long, customized for a wide array of research uses. Ansa’s innovative enzymatic synthesis method consistently generates complex DNA structures, inclusive of repeats and secondary structures, with high adaptability.

View the full report here:

https://www.thebusinessresearchcompany.com/report/oligonucleotide-synthesis-global-market-report

What Are the Key Elements That Define the Oligonucleotide Synthesis Market?

Oligonucleotide synthesis is the chemical linking of nucleotides, precisely forming the desired sequenced product. This process is helpful in modern laboratory practice as it offers quick and affordable access to oligonucleotides manufactured to order with the necessary sequence.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12176

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theOligonucleotide Synthesis Market?

The increase in chronic diseases is predicted to drive the growth of the oligonucleotide synthesis market. Chronic diseases are defined as conditions that persist for over a year and need ongoing medical care, which could potentially worsen with time. Oligonucleotides have the ability to affect the gene expression responsible for chronic diseases through various ways. They have the potential to target mRNA, pre-mRNA, or non-coding RNA to control splicing events, stimulate degradation or disrupt protein translation. For example, the World Health Organization, a specialized agency of the United Nations based in Switzerland, reported in September 2022 that out of the 41 million global deaths, 74% were due to non-communicable diseases (NCDs) or chronic diseases. The report further detailed that there were 17.9 million deaths from cardiovascular diseases, 9.3 million deaths from cancer, 4.1 million deaths resulting from chronic respiratory diseases, and 2.0 million deaths from diabetes. Hence, the escalating prevalence of chronic and rare diseases is fuelling the growth of the oligonucleotide synthesis market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12176&type=smp

#What Are the Key Projections for the CAGR of the Oligonucleotide Synthesis Market From 2025 to 2034?

The market size of oligonucleotide synthesis has seen quick expansion in the past few years. The market is expected to swell from $10.33 billion in 2024 to $11.94 billion in 2025, marking a compound annual growth rate (CAGR) of 15.6%. The historical period’s growth is closely related to improvements in biomedical research, advancements in therapeutic development, innovative strides in biotechnology, genomic investigations, and the steady surge in DNA technologies.

The market for oligonucleotide synthesis is forecasted to expand considerably in the years to come. Its value is set to reach $22.29 billion by 2029, with a compound annual growth rate (CAGR) of 16.9%. This growth during the forecast period is influenced by the introduction of new diagnostic tools, RNA interference (RNAi) treatments, regenerative medicine, nanotechnology uses, and gene editing advancements. The forecast period will likely see trends such as targeted drug creation, innovative distribution systems, automated synthesis, CRISPR-cas technology, and next-generation sequencing (NGS).

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12176

What Are the Current Market Growth and Trends in the Oligonucleotide Synthesis Market That Industry Players Should Watch?

The primary trend that is becoming increasingly prominent in the oligonucleotide synthesis market is product innovation. To maintain their market standing, major firms are creating inventive products. As an example, Ansa Biotechnologies, Inc., an American company that specializes in manufacturing complex DNA, launched Ansa Clonal DNA and Ansa DNA Fragments in July 2024. Ansa Clonal DNA offers clonal, flawless sequences of DNA up to 600 base pairs long, negating the need for assembly, and providing superior accuracy for intricate synthetic biology projects. This product guarantees errorless, ready-to-use DNA sequences thereby rendering it a trustworthy choice for scientists. Similarly, Ansa DNA Fragments provide sequence-verified linear double-stranded DNA fragments, up to 600 base pairs as well, designed for assorted research uses. Utilizing their pioneering enzymatic synthesis technique, Ansa consistently produces complex DNA structures, inclusive of repeats and secondary structures, with great accuracy.

What Are the Major Market Players Making an Impact on theOligonucleotide Synthesis Market Growth?

Major companies operating in the oligonucleotide synthesis market include Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, GE HealthCare Technologies Inc., Eurofins Scientific SE, Agilent Technologies Inc., Nitto Denko Avecia Inc., Alnylam Pharmaceuticals Inc., Maravai Life Sciences, LGC Limited, Ionis Pharmaceuticals Inc., GenScript Inc., Ajinomoto Bio-Pharma Services, Sarepta Therapeutics Inc., Integrated DNA Technologies Inc., Twist Bioscience Corporation, Eurogentec SA, Kaneka Eurogentec S.A., Biocomma Limited, Bio-Synthesis Inc., TriLink BioTechnologies Incorporated, Generi Biotech s.r.o., ATDBio Ltd., BioAutomation Corporation, Biolegio B.V., Dharmacon Research Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/oligonucleotide-synthesis-global-market-report

How Are the Key Segments of the Oligonucleotide Synthesis Market Driving Opportunities and Innovations?

The oligonucleotide synthesis market covered in this report is segmented –

1) By Type: Custom Oligos, Predesigned Oligos

2) By Product Type: Oligonucleotides, Reagents, Equipment, Services, Purification, Modification

3) By Application: Therapeutic Applications, Research Applications, Diagnostic Applications

Subsegments:

1) By Custom Oligos: Long Oligonucleotides, Short Oligonucleotides, Modified Oligonucleotides

2) By Predesigned Oligos: Gene-Specific Oligos, Probe Oligos, Primers For PCR And RT-PCR

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=12176&type=smp

What Regions Are At the Forefront of #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theOligonucleotide Synthesis Market?# Market Expansion?

North America was the largest region in the oligonucleotide synthesis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oligonucleotide synthesis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Gobal Oligonucleotide Synthesis Maret 2025, By The Business Research Company:

Soap And Cleaning Compounds Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/soap-and-cleaning-compounds-global-market-report

Vegan Cosmetics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/vegan-cosmetics-global-market-report

Hand Cream and Hand Lotion Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/hand-cream-and-hand-lotions-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the oligonucleotide synthesis market size evolved in recent years?

The market size for oligonucleotide synthesis has significantly expanded in the past few years. The market is set to rise from a worth of $10.33 billion in 2024 to an impressive $11.94 billion in 2025, yielding a compound annual growth rate (CAGR) of 15.6%. The expansion during the historical period can be traced back to progressive advancements in biomedical research, therapeutic development, innovation in biotechnology, genomic investigations, and an upsurge in DNA technologies.

What are the predictions for the oligonucleotide synthesis market size in the coming years?

In the upcoming years, the oligonucleotide synthesis market size is projected to witness quick expansion. The market size is forecasted to reach $22.29 billion in 2029 with a compound annual growth rate (CAGR) of 16.9%. The surge during the forecast period can be credited to the emergence of diagnostic tools, RNA interference (RNAi) therapies, regenerative medicine, the application of nanotechnology, and progress in gene editing. The forecast period will likely see trends such as specifically targeted drug development, groundbreaking delivery systems, automated synthesis, CRISPR-cas technology, and next-generation sequencing (NGS).

Get your oligonucleotide synthesis market report here!

https://www.thebusinessresearchcompany.com/report/oligonucleotide-synthesis-global-market-report

What key factors are fueling the growth of the oligonucleotide synthesis market?

The escalating occurrence of chronic illnesses is projected to spur the expansion of the oligonucleotide synthesis market in the future. Chronic diseases are conditions that persist for over a year and demand constant medical care, and they can potentially deteriorate over time. Oligonucleotides influence the gene expression that leads to these chronic conditions through various methods. They can influence mRNA, pre-mRNA, or non-coding RNA to alter splicing events, instigate degradation, or obstruct protein translation. For example, in September 2022, the World Health Organization, a specialised agency of the United Nations based in Switzerland, reported 41 million fatalities, accounting for 74% of deaths triggered by non-communicable diseases (NCDs) or chronic diseases worldwide every year. The figures included 17.9 million deaths from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. Hence, the increasing occurrence of chronic and rare illnesses is fuelling the growth of the oligonucleotide synthesis market.

How is the global oligonucleotide synthesis market divided into key segments?

The oligonucleotide synthesis market covered in this report is segmented –

1) By Type: Custom Oligos, Predesigned Oligos

2) By Product Type: Oligonucleotides, Reagents, Equipment, Services, Purification, Modification

3) By Application: Therapeutic Applications, Research Applications, Diagnostic Applications

Subsegments:

1) By Custom Oligos: Long Oligonucleotides, Short Oligonucleotides, Modified Oligonucleotides

2) By Predesigned Oligos: Gene-Specific Oligos, Probe Oligos, Primers For PCR And RT-PCR

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12176&type=smp

Who are the key firms paving the way for growth in the oligonucleotide synthesis market?

Major companies operating in the oligonucleotide synthesis market include Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, GE HealthCare Technologies Inc., Eurofins Scientific SE, Agilent Technologies Inc., Nitto Denko Avecia Inc., Alnylam Pharmaceuticals Inc., Maravai Life Sciences, LGC Limited, Ionis Pharmaceuticals Inc., GenScript Inc., Ajinomoto Bio-Pharma Services, Sarepta Therapeutics Inc., Integrated DNA Technologies Inc., Twist Bioscience Corporation, Eurogentec SA, Kaneka Eurogentec S.A., Biocomma Limited, Bio-Synthesis Inc., TriLink BioTechnologies Incorporated, Generi Biotech s.r.o., ATDBio Ltd., BioAutomation Corporation, Biolegio B.V., Dharmacon Research Inc.

Which trends are expected to transform the oligonucleotide synthesis market?

In the oligonucleotide synthesis market, the trend that is gaining significant traction revolves around product innovation. To stay competitive, leading corporations are introducing novel products. For instance, Ansa Biotechnologies, Inc., a US firm that specializes in complex DNA production, rolled out Ansa Clonal DNA and Ansa DNA Fragments in July 2024. The former is capable of providing clonal, sequence-perfect DNA up to 600 base pairs long, thus eliminating assembly requirements and providing unmatched accuracy for intricate synthetic biology projects. This product guarantees error-free and ready-for-use DNA sequences, making it a dependable option for scientists. On the other hand, Ansa DNA Fragments provide sequence-verified linear double-stranded DNA fragments up to 600 base pairs, custom-made for various research purposes. By employing an innovative enzymatic synthesis method, Ansa consistently produces complex DNA constructs, such as repeats and secondary structures, with extreme precision.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12176

What regions are contributing significantly to the growth of the oligonucleotide synthesis market?

North America was the largest region in the oligonucleotide synthesis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oligonucleotide synthesis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Soap And Cleaning Compounds Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/soap-and-cleaning-compounds-global-market-report

Vegan Cosmetics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/vegan-cosmetics-global-market-report

Hand Cream and Hand Lotion Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/hand-cream-and-hand-lotions-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What Growth Opportunities are Expected to Drive the Oligonucleotide Synthesis Market’s CAGR Through 2034?

The oligonucleotide synthesis market has grown rapidly in recent years. It is expected to increase from $10.33 billion in 2024 to $11.94 billion in 2025, at a CAGR of 15.6%. This expansion has been fueled by advancements in biomedical research, therapeutic developments, biotechnology innovations, genomic studies, and the increasing use of DNA technologies.

The oligonucleotide synthesis market is set to expand rapidly, reaching $22.29 billion by 2029 with a CAGR of 16.9%. Growth will be fueled by advancements in diagnostic tools, increasing applications of RNA interference (RNAi) therapies, developments in regenerative medicine, progress in nanotechnology, and innovations in gene editing. Major trends will include targeted drug development, the introduction of novel delivery systems, automation in synthesis processes, advancements in CRISPR-Cas technology, and the expansion of next-generation sequencing (NGS).

What Drivers Are Shaping the Growth of the oligonucleotide synthesis Market?

The increasing prevalence of chronic diseases is expected to drive the growth of the oligonucleotide synthesis market. Oligonucleotides help manage chronic diseases by targeting specific genes or RNA, potentially modulating gene expression to treat these conditions. The World Health Organization reported in September 2022 that 74% of global deaths are due to non-communicable diseases, with cardiovascular diseases and cancer as major contributors. This rise in chronic diseases is promoting the growth of the oligonucleotide synthesis market.

Get Your Free Sample of the Global Oligonucleotide Synthesis Market Report Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=12176&type=smp

What Are the Leading Industry Players Dominating the Oligonucleotide Synthesis Market?

Major companies operating in the oligonucleotide synthesis market include:

• Thermo Fisher Scientific Inc._x000D_

• Danaher Corporation_x000D_

• Merck KGaA_x000D_

• GE HealthCare Technologies Inc._x000D_

• Eurofins Scientific SE_x000D_

What Are the Latest Trends Leading to Disruption in the Oligonucleotide Synthesis Market?

Product innovation is also a key trend in the oligonucleotide synthesis market. Companies in this market are developing new products to maintain their competitive position. For example, in July 2024, Ansa Biotechnologies, Inc., a US-based manufacturer of complex DNA, launched Ansa Clonal DNA and Ansa DNA Fragments. Ansa Clonal DNA provides sequence-perfect, clonal DNA up to 600 base pairs, eliminating assembly needs, while Ansa DNA Fragments offers verified linear double-stranded DNA for a variety of research applications, produced with high precision through an enzymatic synthesis process.

Get Instant Access to the Global Oligonucleotide Synthesis Market Report with Swift Delivery!

https://www.thebusinessresearchcompany.com/report/oligonucleotide-synthesis-global-market-report

What Major Market Segments Define the Scope and Growth of the Oligonucleotide Synthesis Market?

The oligonucleotide synthesis market covered in this report is segmented –

1) By Type: Custom Oligos, Predesigned Oligos

2) By Product Type: Oligonucleotides, Reagents, Equipment, Services, Purification, Modification

3) By Application: Therapeutic Applications, Research Applications, Diagnostic Applications

Subsegments:

1) By Custom Oligos: Long Oligonucleotides, Short Oligonucleotides, Modified Oligonucleotides

2) By Predesigned Oligos: Gene-Specific Oligos, Probe Oligos, Primers For PCR And RT-PCR

Which Regions Are Significant to the Growth of the Oligonucleotide Synthesis Market?

North America was the largest region in the oligonucleotide synthesis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oligonucleotide synthesis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

How Can We Define the Oligonucleotide Synthesis Market and Its Key Components?

Oligonucleotide synthesis is the chemical linking of nucleotides, precisely forming the desired sequenced product. This process is helpful in modern laboratory practice as it offers quick and affordable access to oligonucleotides manufactured to order with the necessary sequence.

Browse Through More Similar Reports By The Business Research Company:

Soap And Cleaning Compounds Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/soap-and-cleaning-compounds-global-market-report

Vegan Cosmetics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/vegan-cosmetics-global-market-report

Hand Cream and Hand Lotion Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/hand-cream-and-hand-lotions-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: